Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...

June 13 (Reuters) - Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals’ REGN.O offer for the DNA-testing company ...

During her remarks in a Senate hearing this month, Senator Amy Klobuchar got into a tense exchange with 23andMe CEO Joe Selsavage over privacy concerns.

The longevity industry has reached an inflection point. What once seemed like science fiction-reversing aging, optimizing human performance, and extending healthspan-is now attracting serious ...